These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Retiform purpura in plaques: a morphological approach to diagnosis. Jones A; Walling H Clin Exp Dermatol; 2007 Sep; 32(5):596-602. PubMed ID: 17489989 [TBL] [Abstract][Full Text] [Related]
7. Dermatoporosis: a chronic cutaneous insufficiency/fragility syndrome. Clinicopathological features, mechanisms, prevention and potential treatments. Kaya G; Saurat JH Dermatology; 2007; 215(4):284-94. PubMed ID: 17911985 [TBL] [Abstract][Full Text] [Related]
8. Thrombomodulin as a marker for bleeding complications during warfarin treatment. Lind M; Boman K; Johansson L; Nilsson TK; Ohlin AK; Birgander LS; Jansson JH Arch Intern Med; 2009 Jul; 169(13):1210-5. PubMed ID: 19597070 [TBL] [Abstract][Full Text] [Related]
9. Perioperative international normalized ratio level is a poor predictor of postoperative bleeding complications in dermatological surgery patients taking warfarin. Blasdale C; Lawrence CM Br J Dermatol; 2008 Mar; 158(3):522-6. PubMed ID: 18241270 [TBL] [Abstract][Full Text] [Related]
10. Bleeding complications with warfarin use: a prevalent adverse effect resulting in regulatory action. Wysowski DK; Nourjah P; Swartz L Arch Intern Med; 2007 Jul; 167(13):1414-9. PubMed ID: 17620536 [TBL] [Abstract][Full Text] [Related]
11. [Cutaneous drug reactions induced by glycopeptides]. Prey S; Sparsa A; Boumediene A; Bonnetblanc JM; Weinbreck P; Denes E Med Mal Infect; 2007 May; 37(5):270-4. PubMed ID: 17434698 [TBL] [Abstract][Full Text] [Related]
13. Nonpalpable purpura within a setting of anticoagulant therapy and metastatic carcinoma. Grenier N; Chen-Tsai C Int J Low Extrem Wounds; 2006 Sep; 5(3):200-3. PubMed ID: 16928675 [TBL] [Abstract][Full Text] [Related]
14. Hypersensitivity reactions to anticoagulant drugs: diagnosis and management options. Bircher AJ; Harr T; Hohenstein L; Tsakiris DA Allergy; 2006 Dec; 61(12):1432-40. PubMed ID: 17073874 [TBL] [Abstract][Full Text] [Related]
15. Warfarin-induced skin necrosis in a patient with heparin-induced thrombocytopenia: two diseases or one? Abdel-Wahab OI; Rosovsky RP; Warth JA Acta Haematol; 2008; 120(2):117-22. PubMed ID: 19018128 [TBL] [Abstract][Full Text] [Related]
16. Cutaneous manifestations in relation to immunologic parameters in a cohort of primary myelodysplastic syndrome patients. Dalamaga M; Karmaniolas K; Matekovits A; Migdalis I; Papadavid E J Eur Acad Dermatol Venereol; 2008 May; 22(5):543-8. PubMed ID: 18070024 [TBL] [Abstract][Full Text] [Related]
17. Malignancy-associated venous thrombosis with concurrent warfarin-induced skin necrosis, venous limb gangrene and thrombotic microangiopathy. Ng HJ; Crowther MA Thromb Haemost; 2006 Jun; 95(6):1038-9. PubMed ID: 16732387 [No Abstract] [Full Text] [Related]
18. Intravenous immunoglobulin-induced, non-eczematous, vesiculobullous eruptions in Stevens-Johnson syndrome. Lin WL; Lin WC; Chang YC; Yang LC; Hung SI; Hong HS; Chung WH Am J Clin Dermatol; 2009; 10(5):339-42. PubMed ID: 19658448 [TBL] [Abstract][Full Text] [Related]
19. Cutaneous surgery in patients on warfarin therapy. Nelms JK; Wooten AI; Heckler F Ann Plast Surg; 2009 Mar; 62(3):275-7. PubMed ID: 19240524 [TBL] [Abstract][Full Text] [Related]
20. Interaction between warfarin and cranberry juice. Aston JL; Lodolce AE; Shapiro NL Pharmacotherapy; 2006 Sep; 26(9):1314-9. PubMed ID: 16945054 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]